Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Dis Colon Rectum. 2012 May;55(5):509–514. doi: 10.1097/DCR.0b013e3182420953

Table 2.

Pathologic characteristics and treatment of adenocarcinoma (AC) vs. adenosquamous carcinoma (ASC)

AC ASC P-value*
Stage (%) <0.001
 I 25497 (24.4%) 6 (6.4%)
 II 37461 (35.8%) 28 (30.1%)
 III 27104 (25.9%) 25 (26.9%)
 IV 14567 (13.9%) 34 (36.6%)
Histological Grade <0.001
 Well differentiated 10207 (9.6%) 1(1.1%)
 Moderately differentiated 74283 (70.1%) 27(28.7%)
 Poorly differentiated 20928 (19.7%) 62(66.0%)
 Undifferentiated 597 (0.6%) 4(4.2%)
Location 0.01
 Proximal and transverse colon 48912 (44.0%) 56(56.3%)
 Descending colon 4891 (4.4%) 0(0.0%)
 Sigmoid colon 26457 (23.8%) 14(14.1%)
 Rectosigmoid 9672 (8.7%) 8(8.5%)
 Rectum 19676 (17.7%) 18(18.3%)
 Unknown 1556 (1.4%) 3(2.8%)
Radiation 0.760
 No radiation 100036 (90.0%) 90(90.9%)
 Radiation 11128 (10.0%) 9(9.1%)
Chemotherapy 0.101
 No 72316 (65.1%) 55(55.6%)
 Yes 34917 (31.3%) 41(41.4%)
 Unknown 3931 (3.6%) 3(3.0%)
Surgery 0.003
 Local excision 5386 (4.8%) 1 (1.0%)
 Partial colectomy 51267 (46.1%) 38 (38.4%)
 Subtotal colectomy 43353 (39.0%) 41(41.4%)
 Total/proctocolectomy 10291 (9.3%) 19 (19.2%)
 Unknown colectomy 867 (0.8%) 0 (0.0%)
*

P-value < 0.5 considered significant